A Randomized Comparison of Liposomal Daunorubicin/Daunorubicin Combined with Low-Dose Cytarabine and Etoposide or High-Dose Cytarabine and Fludarabine in Induction Treatment of Pediatric AML Using MRD-Based Risk Stratification in the NOPHO-DBH AML 2012 Protocol

Barbara De Moerloose, Nira Arad-Cohen, Daniel Cheuk, Jose Maria Fernandez Navarro, Henrik Hasle, Kirsi Jahnukainen, Gertjan J.L. Kaspers, Zhanna Kovalova, Birgitte Lausen, Ulrika Norén-Nyström, Josefine Palle, Ramune Pasauliene, Cornelis Jan Pronk, Kadri Saks, Anne Maria Tierens, Bernward Zeller, Jonas Abrahamsson

Research output: Contribution to journalMeeting Abstractpeer-review

Original languageEnglish
Article number831
JournalBlood
Volume142
Issue numberSuppl.1
DOIs
Publication statusPublished - 28 Nov 2023
Externally publishedYes
EventASH Annual Meeting - San Diego, United States
Duration: 9 Dec 202312 Dec 2023
https://www.hematology.org/newsroom/annual-meeting-press/press-kit/general-annual-meeting-information-and-materials

Field of Science*

  • 3.2 Clinical medicine

Publication Type*

  • 3.3. Publications in conference proceedings indexed in Web of Science and/or Scopus database

Cite this